Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin’s lymphomas

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2022-02, Vol.36 (2), p.588-590
Hauptverfasser:	Marchesi, Francesco, Pimpinelli, Fulvia, Giannarelli, Diana, Ronchetti, Livia, Papa, Elena, Falcucci, Paolo, Pontone, Martina, Di Domenico, Enea Gino, di Martino, Simona, Laquintana, Valentina, Mandoj, Chiara, Conti, Laura, Cordone, Iole, La Malfa, Antonia, Viggiani, Caterina, Renzi, Daniela, Palombi, Francesca, Romano, Atelda, Pisani, Francesco, Gumenyuk, Svitlana, Di Bella, Ornella, Vujovic, Branka, Morrone, Aldo, Ciliberto, Gennaro, Ensoli, Fabrizio, Mengarelli, Andrea
Format:	Artikel
Sprache:	eng
Schlagworte:	101/1 631/250/255 692/699/1541/1990/291/1621/1915 Aged Aged, 80 and over Antibodies, Monoclonal - therapeutic use Antigens, CD20 - immunology BNT162 Vaccine - administration & dosage Cancer Cancer Research CD20 antigen Coronaviruses COVID-19 - immunology COVID-19 - prevention & control COVID-19 vaccines Critical Care Medicine Drug dosages Female Follow-Up Studies Genomes Hematology Humans Intensive Internal Medicine Letter Leukemia Lymphocytes B Lymphoma Lymphoma, B-Cell - blood Lymphoma, B-Cell - drug therapy Lymphoma, B-Cell - virology Lymphoma, Non-Hodgkin - blood Lymphoma, Non-Hodgkin - drug therapy Lymphoma, Non-Hodgkin - virology Male Medicine Medicine & Public Health Monoclonal antibodies Non-Hodgkin's lymphoma Oncology Pandemics Patients Prognosis Severe acute respiratory syndrome coronavirus 2 Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	0887-6924 1476-5551
DOI:	10.1038/s41375-021-01418-8